Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Sanaz Tabarestani"'
Publikováno v:
International Journal of Cancer Management.
Context: Triple negative breast cancers (TNBC) constitute about 15% of breast neoplasms. In contrast to estrogen receptor (ER) or human epidermal growth factor receptor (HER2) positive breast cancers, which respond to hormonal therapy (such as tamoxi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::96017a4aa7f06bfdd7d8db4f1c10d505
https://doi.org/10.5812/ijcm.87024
https://doi.org/10.5812/ijcm.87024
Publikováno v:
International Journal of Cancer Management.
Context: One of the most important achievements in cancer research is the development of cancer immunotherapy. However, only a subset of patients respond to immunotherapy modalities, and few patients respond for a durable time. Here, we review the po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33d4025dc02bc10a477c382dc8533281
https://doi.org/10.5812/ijcm.85552
https://doi.org/10.5812/ijcm.85552
Autor:
Marzieh Motallebi, Mohammad Esmaeil Akbari, Sanaz Tabarestani, Leyla Shojaee, Mona Malekzadeh Moghani
Publikováno v:
International Journal of Cancer Management. 10
Background: Breast cancer is the most frequent malignancy in Iranian women. Pathogenic mutations in BRCA1 and BRCA2 genes account for 20% to 25% of familial breast cancer. BRCA1 and BRCA2 mutation frequencies differ considerably among various geograp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d9bc7bdf530c1c6cf431bb0a0a25450
https://doi.org/10.5812/ijcm.60392
https://doi.org/10.5812/ijcm.60392
Publikováno v:
Iranian Journal of Cancer Prevention
Context: Breast cancer is the most common cancer in women worldwide. Estrogen receptor (ER) positive breast cancer constitutes the majority of these cancers. Hormone therapy has significantly improved clinical outcomes for early- and late-stage hormo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::977268214f19169560335cb25eefeb99
https://doi.org/10.17795/ijcp-6565
https://doi.org/10.17795/ijcp-6565
Autor:
Abolfazl Movafagh, Sanaz Tabarestani
Publikováno v:
Iranian Journal of Cancer Prevention
Context: Chronic myeloid leukemia (CML) is a myeloproliferative disorder characterized by overproduction of immature and matured myeloid cells in the peripheral blood, bone marrow and spleen. Evidence Acquisition: A hallmark of CML is the presence of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab9b8a7e142b8f6ffcaede879f028c53
http://europepmc.org/articles/PMC4922205
http://europepmc.org/articles/PMC4922205
Publikováno v:
Asian Pacific journal of cancer prevention : APJCP. 16(17)
Gene amplification is an important mechanism in the development and progression of cancer. Currently, gene amplification status is generally determined by in situ hybridization (ISH). Multiplex ligation-dependent probe amplification (MLPA) is a PCR-b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2076661853281cb74a15faf256e1ef62
https://pubmed.ncbi.nlm.nih.gov/26625832
https://pubmed.ncbi.nlm.nih.gov/26625832
Publikováno v:
Medical Oncology. 31
Approximately 70 % of breast cancers are estrogen receptor (ER) positive, and interfering with estrogen action with tamoxifen has been the treatment of choice for ER-positive breast cancer patients. However, about a third of patients treated with tam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cce0f2f14a37bbf8d8931b878d9a4d0b
https://doi.org/10.1007/s12032-014-0896-5
https://doi.org/10.1007/s12032-014-0896-5
Publikováno v:
Immunotherapy. 6(2)
Cancer–testis (CT) antigens are tumor-associated antigens attracting immunologists for their possible application in the immunotherapy of cancer. Several clinical trials have assessed their therapeutic potentials in cancer patients. Breast cancers,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::280cbbf9ec96bafa04dd00f76828c49f
https://pubmed.ncbi.nlm.nih.gov/24491090
https://pubmed.ncbi.nlm.nih.gov/24491090
Autor:
Afshin Rakhsha, Sayyed Mohammad Hossein Ghaderian, Eznollah Azargashb, Jahangir Rafat, Abdolali Ebrahimi, Hamid Rezvani, Naser Kamalian, Reza Mirfakhraie, Hamid Attarian, M Ghadyani, Hossein Afshin Alavi, Sanaz Tabarestani
Publikováno v:
Cellular oncology (Dordrecht). 37(2)
Breast cancer is a leading cause of morbidity and mortality in women worldwide. About 70 % of breast cancers are estrogen receptor (ER) positive. Blocking estrogen action by tamoxifen has been the treatment of choice in ER positive breast cancers for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::306618100bb5104883bd97f9d991f383
https://pubmed.ncbi.nlm.nih.gov/24573687
https://pubmed.ncbi.nlm.nih.gov/24573687
Publikováno v:
Scopus-Elsevier
The cancer stem cell (CSC) model states that cancers are organized in cellular hierarchies, which explains the functional heterogeneity often seen in tumors. Like normal tissue stem cells, CSCs are capable of self-renewal, either by symmetric or asym
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::855a8b75f2f980ad9bf73a1510b47784
https://pubmed.ncbi.nlm.nih.gov/23464384
https://pubmed.ncbi.nlm.nih.gov/23464384